Evidence map›Paper›PMID 35324924›Full record

ArticlePloS one2022

Metal nanoparticles assisted revival of Streptomycin against MDRS Staphylococcus aureus.

Nadia Ghaffar, Sumera Javad, Muhammad Akhyar Farrukh, Anis Ali Shah, Mansour K Gatasheh, Bander M A Al-Munqedhi, Ozair Chaudhry

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Antimicrobial Mechanisms of Metal-Based Nanomaterials.International journal of nanomedicine · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Green Synthesis of Novel Silver Nanoparticles UsingInternational journal of molecular sciences · 2024
    Article
  20. Hexagonal zinc oxide nanoparticles: a novel approach to combat multidrug-resistantFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Nadia GhaffarDepartment of Botany, Lahore College for Women University, Lahore, Pakistan.
Sumera JavadDepartment of Botany, Lahore College for Women University, Lahore, Pakistan.ORCID 0000-0002-4703-9610
Muhammad Akhyar FarrukhDepartment of Chemistry, Forman Christian College (A Chartered University), Lahore, Pakistan.ORCID 0000-0002-1118-8657
Anis Ali ShahDepartment of Botany, University of Education, Lahore, Pakistan.ORCID 0000-0003-2071-9939
Mansour K GatashehDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.ORCID 0000-0002-0101-1014
Bander M A Al-MunqedhiDepartment Botony and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Ozair ChaudhryOntario Institute of Agrologist, Ontario, Canada.
King Saud University · SALahore College for Women University · PKAgricultural Research Institute of Ontario · CAForman Christian College · PKUniversity of Okara · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability of microorganisms to generate resistance outcompetes with the generation of new and efficient antibiotics. Therefore, it is critically required to develop novel antibiotic agents and treatments to control bacterial infections. Green synthesized metallic and metal oxide nanoparticles are considered as the potential means to target bacteria as an alternative to antibiotics. Nanoconjugates have also attracted attention because of their increased biological activity as compared to free antibiotics. In the present investigation, silver nanoparticles (AgNPs), zinc oxide nanoparticles (ZnO NPs), copper oxide nanoparticles (CuO NPs), and iron oxide nanoparticles (FeO NPs) have been synthesized by using leaf extract of Ricinus communis. Characterization of nanoparticles was done by using UV-Vis Spectroscopy, Fourier Transform Infrared Spectroscopy, Scanning Electron Microscopy, Energy Dispersive X-Ray Analyzer, X-ray Diffraction Analysis, and Dynamic Light Scattering Particle Size Analyzer. Interestingly, Streptomycin when combined with AgNPs, ZnO NPs, CuO NPs, and FeO NPs showed enhanced antibacterial activity against clinical isolates of S. aureus which suggested synergism between the nanoparticles and antibiotics. The highest enhanced antibacterial potential of Streptomycin was observed in conjugation with ZnO NPs (11 ± 0.5 mm) against S. aureus. Minimum inhibitory concentration of conjugates of AgNPs, ZnO NPs, CuO NPs, and FeO NPs with streptomycin against S. aureus was found to be 3.12, 2.5,10, and 12.5 μg/mL respectively. The considerable point of the present investigation is that S. aureus, which was resistant to streptomycin becomes highly susceptible to the same antibiotic when combined with nanoparticles. This particular observation opens up windows to mitigate the current crisis due to antibiotic resistance to combat antimicrobial infections efficiently.

Indexed as

Metal NanoparticlesZinc OxideAnti-Bacterial AgentsMicrobial Sensitivity TestsPlant ExtractsSilverSpectroscopy, Fourier Transform InfraredStaphylococcus aureusStreptomycinX-Ray DiffractionAnti-Bacterial AgentsPlant ExtractsSilverStreptomycinZinc Oxide

Identifiers

PMID35324924
PMCPMC8947119
OpenAlexW4221001036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.